Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (41-50 of 318) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2019
Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goalEdoardo G Giannini, Alessio Aghemo
Gut|September 7, 2014
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis CAlessio Aghemo, Raffaele De Francesco
Expert Opinion on Biological Therapy|January 22, 2011
Interferon in the treatment of chronic hepatitis C: a drug caught between past and futureElena Vezali, Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2019
Liver International: Anticipating the future of hepatology worldwideLuca Valenti, Alessio Aghemo, Alejandro Forner
Journal of Hepatology|July 4, 2012
Assessing long-term treatment efficacy in chronic hepatitis B and C: between evidence and common senseAlessio Aghemo, Pietro Lampertico, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2023
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver InternationalAlessio Aghemo, Alejandro Forner, Luca Valenti
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: should we abandon HCV genotype testing? MaybeMaria Corina Plaz Torres, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null respondersEnrico Galmozzi, Alessio Aghemo, Massimo Colombo
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2012
Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trialsAlessio Aghemo, Elisabetta Degasperi, Massimo Colombo
Pageof 32

Showing results (41-50 of 318) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2019
Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goalEdoardo G Giannini, Alessio Aghemo
Gut|September 7, 2014
Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis CAlessio Aghemo, Raffaele De Francesco
Expert Opinion on Biological Therapy|January 22, 2011
Interferon in the treatment of chronic hepatitis C: a drug caught between past and futureElena Vezali, Alessio Aghemo, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2019
Liver International: Anticipating the future of hepatology worldwideLuca Valenti, Alessio Aghemo, Alejandro Forner
Journal of Hepatology|July 4, 2012
Assessing long-term treatment efficacy in chronic hepatitis B and C: between evidence and common senseAlessio Aghemo, Pietro Lampertico, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2023
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver InternationalAlessio Aghemo, Alejandro Forner, Luca Valenti
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: should we abandon HCV genotype testing? MaybeMaria Corina Plaz Torres, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null respondersEnrico Galmozzi, Alessio Aghemo, Massimo Colombo
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2012
Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trialsAlessio Aghemo, Elisabetta Degasperi, Massimo Colombo
Pageof 32